Improved Survival with Ipilimumab in Patients with Metastatic Melanoma

Hodi, F. Stephen, O'Day, Steven J., McDermott, David F., Weber, Robert W., Sosman, Jeffrey A., Haanen, John B., Gonzalez, Rene, Robert, Caroline +21 more·2010·New England Journal of Medicine

DOI 10.1056/nejmoa1003466

Cited by (439)

Items 301–400 of 439

Is There a Clinical Future for IDO1 Inhibitors After the Failure of Epacadostat in Melanoma?
Van den Eynde, Benoit J., van Baren, Nicolas, Baurain, Jean-François · 2020 · Annual Review of Cancer Biology
Broad-spectrum therapeutic suppression of metastatic melanoma through nuclear hormone receptor activation
Pencheva, Nora, Buss, Colin G., Posada, Jessica, Merghoub, Taha, Tavazoie, Sohail F. · 2014 · Cell
Genetic evolution of T-cell resistance in the course of melanoma progression
Sucker, Antje, Zhao, Fang, Real, Birgit, Heeke, Christina, Bielefeld, Nicola, Maβen, Stefan, Horn, Susanne, Moll, Iris, Maltaner, Raffaela, Horn, Peter A. et al. · 2014 · Clinical Cancer Research
Highly efficient singlet oxygen generation, two-photon photodynamic therapy and melanoma ablation by rationally designed mitochondria-specific near-infrared AIEgens
Zheng, Zheng, Liu, Haixiang, Zhai, Shaodong, Zhang, Haoke, Shan, Guogang, Kwok, Ryan T. K., Ma, Chao, Sung, Herman H. Y., Williams, Ian D., Lam, Jacky W. Y. et al. · 2020 · Chemical Science
Complete response of metastatic melanoma in a patient with Crohn’s disease simultaneously receiving anti-α4β7 and anti-PD1 antibodies
Frohne, Christopher C., Llano, Ernesto M., Perkovic, Ashley, Cohen, Russell D., Luke, Jason J. · 2019 · Journal for ImmunoTherapy of Cancer
Angiopoietin-2 as a Biomarker and Target for Immune Checkpoint Therapy
Wu, Xinqi, Giobbie-Hurder, Anita, Liao, Xiaoyun, Connelly, Courtney, Connolly, Erin M., Li, Jingjing, Manos, Michael P., Lawrence, Donald, McDermott, David, Severgnini, Mariano et al. · 2017 · Cancer Immunology Research
Gastrointestinal and Hepatic Complications of Immune Checkpoint Inhibitors
Cramer, Peyton, Bresalier, Robert S. · 2017 · Current Gastroenterology Reports
Looking beyond the hype: applied AI and machine learning in translational medicine
Toh, Tzen S., Dondelinger, Frank, Wang, Dennis · 2019 · EBioMedicine
Association of antithyroglobulin antibodies with the development of thyroid dysfunction induced by nivolumab
Kimbara, Shiro, Fujiwara, Yutaka, Iwama, Shintaro, Ohashi, Ken, Kuchiba, Aya, Arima, Hiroshi, Yamazaki, Naoya, Kitano, Shigehisa, Yamamoto, Noboru, Ohe, Yuichiro · 2018 · Cancer Science
Characterization of Thyroid Disorders in Patients Receiving Immune Checkpoint Inhibition Therapy
Lee, Hyunju, Hodi, F. Stephen, Giobbie-Hurder, Anita, Ott, Patrick A., Buchbinder, Elizabeth I., Haq, Rizwan, Tolaney, Sara, Barroso-Sousa, Romualdo, Zhang, Kevin, Donahue, Hilary et al. · 2017 · Cancer Immunology Research
Immune checkpoint inhibitor toxicities
Marin-Acevedo, Julian A., Chirila, Razvan M., Dronca, Roxana S. · 2019 · Mayo Clinic Proceedings
CTLA4 blockade induces frequent tumor infiltration by activated lymphocytes regardless of clinical responses in humans
Huang, Rong Rong, Jalil, Jason, Economou, James S., Chmielowski, Bartosz, Koya, Richard C., Mok, Stephen, Sazegar, Hooman, Seja, Elizabeth, Villanueva, Arturo, Gomez-Navarro, Jesus et al. · 2011 · Clinical Cancer Research
Monoclonal antibodies against GARP/TGF-β1 complexes inhibit the immunosuppressive activity of human regulatory T cells in vivo
Cuende, Julia, Liénart, Stéphanie, Dedobbeleer, Olivier, van der Woning, Bas, De Boeck, Gitte, Stockis, Julie, Huygens, Caroline, Colau, Didier, Somja, Joan, Delvenne, Philippe et al. · 2015 · Science Translational Medicine
Coordinate Autophagy and mTOR Pathway Inhibition Enhances Cell Death in Melanoma
Xie, Xiaoqi, White, Eileen P., Mehnert, Janice M. · 2013 · PLoS ONE
Targeting the interleukin-17 immune axis for cancer immunotherapy
Vitiello, Gerardo A., Miller, George · 2020 · Journal of Experimental Medicine
Phase I/II study of pegylated arginine deiminase (ADI-PEG 20) in patients with advanced melanoma
Ott, Patrick A., Carvajal, Richard D., Pandit-Taskar, Neeta, Jungbluth, Achim A., Hoffman, Eric W., Wu, Bor-Wen, Bomalaski, John S., Venhaus, Ralph, Pan, Linda, Old, Lloyd J. et al. · 2013 · Investigational New Drugs
Immune Checkpoint Inhibitors in Organ Transplant Patients
Kittai, Adam S., Oldham, Hayden, Cetnar, Jeremy, Taylor, Matthew · 2017 · Journal of Immunotherapy
Role of the intestinal microbiome and microbial-derived metabolites in immune checkpoint blockade immunotherapy of cancer
Hayase, Eiko, Jenq, Robert R. · 2021 · Genome Medicine
The Tumor Microenvironment: A Pitch for Multiple Players
Schiavoni, Giovanna, Gabriele, Lucia, Mattei, Fabrizio · 2013 · Frontiers in Oncology
Neuropilin-1: a checkpoint target with unique implications for cancer immunology and immunotherapy
Chuckran, Christopher A, Liu, Chang, Bruno, Tullia C, Workman, Creg J, Vignali, Dario AA · 2020 · Journal for ImmunoTherapy of Cancer
Non-conventional Inhibitory CD4+Foxp3−PD-1hi T Cells as a Biomarker of Immune Checkpoint Blockade Activity
Zappasodi, Roberta, Budhu, Sadna, Hellmann, Matthew D., Postow, Michael A., Senbabaoglu, Yasin, Manne, Sasikanth, Gasmi, Billel, Liu, Cailian, Zhong, Hong, Li, Yanyun et al. · 2018 · Cancer Cell
Ipilimumab treatment decreases monocytic MDSCs and increases CD8 effector memory T cells in long-term survivors with advanced melanoma
de Coaña, Yago Pico, Wolodarski, Maria, Poschke, Isabel, Yoshimoto, Yuya, Yang, Yuan, Nyström, Maria, Edbäck, Ulrika, Brage, Suzanne Eghyazi, Lundqvist, Andreas, Masucci, Giuseppe V. et al. · 2017 · Oncotarget
The spectrum, incidence, kinetics and management of endocrinopathies with immune checkpoint inhibitors for metastatic melanoma
Scott, Emma S, Long, Georgina V, Guminski, Alexander, Clifton-Bligh, Roderick J, Menzies, Alexander M, Tsang, Venessa H · 2018 · European Journal of Endocrinology
Ocular Toxicity of Targeted Therapies
Renouf, Daniel J., Velazquez-Martin, Juan P., Simpson, Rand, Siu, Lillian L., Bedard, Philippe L. · 2012 · Journal of Clinical Oncology
French Endocrine Society guidance on endocrine side effects of immunotherapy
Castinetti, F, Albarel, F, Archambeaud, F, Bertherat, J, Bouillet, B, Buffier, P, Briet, C, Cariou, B, Caron, Ph, Chabre, O et al. · 2019 · Endocrine Related Cancer
Treatment of NRAS-mutant melanoma
Johnson, Douglas B., Puzanov, Igor · 2015 · Current Treatment Options in Oncology
Colorectal cancer and immunity: What we know and perspectives
Pernot, Simon · 2014 · World Journal of Gastroenterology
Highly efficient homology-driven genome editing in human T cells by combining zinc-finger nuclease mRNA and AAV6 donor delivery
Wang, Jianbin, DeClercq, Joshua J., Hayward, Samuel B., Li, Patrick Wai-Lun, Shivak, David A., Gregory, Philip D., Lee, Gary, Holmes, Michael C. · 2016 · Nucleic Acids Research
Drug development and clinical trials—the path to an approved cancer drug
Rubin, Eric H., Gilliland, D. Gary · 2012 · Nature Reviews Clinical Oncology
Long-term survival and immunological parameters in metastatic melanoma patients who responded to ipilimumab 10 Mg/Kg within an expanded access programme
Di Giacomo, Anna Maria, Calabrò, Luana, Danielli, Riccardo, Fonsatti, Ester, Bertocci, Erica, Pesce, Isabella, Fazio, Carolina, Cutaia, Ornella, Giannarelli, Diana, Miracco, Clelia et al. · 2013 · Cancer Immunology Immunotherapy
Evaluation of CTLA-4 expression and relevance as a novel prognostic factor in patients with non-small cell lung cancer
Salvi, Sandra, Fontana, Vincenzo, Boccardo, Simona, Merlo, Domenico Franco, Margallo, Edoardo, Laurent, Stefania, Morabito, Anna, Rijavec, Erika, Dal Bello, Maria Giovanna, Mora, Marco et al. · 2012 · Cancer Immunology Immunotherapy
A2A Adenosine Receptor Gene Deletion or Synthetic A2A Antagonist Liberate Tumor-Reactive CD8+ T Cells from Tumor-Induced Immunosuppression
Kjaergaard, Jorgen, Hatfield, Stephen, Jones, Graham, Ohta, Akio, Sitkovsky, Michail · 2018 · The Journal of Immunology
Adolescent and young adult patients with cancer: a milieu of unique features
Sender, Leonard, Zabokrtsky, Keri B. · 2015 · Nature Reviews Clinical Oncology
Next-generation peptide vaccines for advanced cancer
Yamada, Akira, Sasada, Tetsuro, Noguchi, Masanori, Itoh, Kyogo · 2013 · Cancer Science
Combination of Immunotherapy With Targeted Therapy: Theory and Practice in Metastatic Melanoma
Yu, Chune, Liu, Xiaowei, Yang, Jiqiao, Zhang, Min, Jin, Hongyu, Ma, Xuelei, Shi, Hubing · 2019 · Frontiers in Immunology
Clinical pharmacology considerations for the development of immune checkpoint inhibitors
Sheng, Jennifer, Srivastava, Shivani, Sanghavi, Kinjal, Lu, Zheng, Schmidt, Brian J., Bello, Akintunde, Gupta, Manish · 2017 · The Journal of Clinical Pharmacology
Uncoupling therapeutic from immunotherapy-related adverse effects for safer and effective anti-CTLA-4 antibodies in CTLA4 humanized mice
Du, Xuexiang, Liu, Mingyue, Su, Juanjuan, Zhang, Peng, Tang, Fei, Ye, Peiying, Devenport, Martin, Wang, Xu, Zhang, Yan, Liu, Yang et al. · 2018 · Cell Research
Stromal fibroblasts mediate anti-PD-1 resistance via MMP-9 and dictate TGFβ inhibitor sequencing in melanoma
Zhao, Fei, Evans, Kathy, Xiao, Christine, DeVito, Nicholas, Theivanthiran, Balamayooran, Holtzhausen, Alisha, Siska, Peter J., Blobe, Gerard C., Hanks, Brent A. · 2018 · Cancer Immunology Research
Selective inhibition of low-affinity memory CD8(+) T cells by corticosteroids
Tokunaga, Akihiro, Sugiyama, Daisuke, Maeda, Yuka, Warner, Allison Betof, Panageas, Katherine S., Ito, Sachiko, Togashi, Yosuke, Sakai, Chika, Wolchok, Jedd D., Nishikawa, Hiroyoshi · 2019 · Journal of Experimental Medicine
Translational Pharmacokinetic/Pharmacodynamic Modeling of Tumor Growth Inhibition Supports Dose-Range Selection of the Anti-PD-1 Antibody Pembrolizumab
Lindauer, A, Valiathan, CR, Mehta, K, Sriram, V, de Greef, R, Elassaiss-Schaap, J, de Alwis, DP · 2017 · CPT: Pharmacometrics & Systems Pharmacology
Intratumoral regulatory T cells: markers, subsets and their impact on anti-tumor immunity
Yano, Hiroshi, Andrews, Lawrence P., Workman, Creg J., Vignali, Dario A. A. · 2019 · Immunology
Hypoxia and the phenomenon of immune exclusion
Pietrobon, Violena, Marincola, Francesco M. · 2021 · Journal of Translational Medicine
Thyroid Dysfunction as an Unintended Side Effect of Anticancer Drugs
Torino, Francesco, Barnabei, Agnese, Paragliola, Rosamaria, Baldelli, Roberto, Appetecchia, Marialuisa, Corsello, Salvatore Maria · 2013 · Thyroid®
Circulating tumour DNA (CtDNA) as a liquid biopsy for melanoma
Calapre, Leslie, Warburton, Lydia, Millward, Michael, Ziman, Mel, Gray, Elin S. · 2017 · Cancer Letters
Hyponatraemia secondary to nivolumab-induced primary adrenal failure
Trainer, Harris, Hulse, Paul, Higham, Claire E, Trainer, Peter, Lorigan, Paul · 2016 · Endocrinology, Diabetes & Metabolism Case Reports
Interdependent IL-7 and IFN-γ signalling in T-cell controls tumour eradication by combined α-CTLA-4+α-PD-1 therapy
Shi, Lewis Zhichang, Fu, Tihui, Guan, Baoxiang, Chen, Jianfeng, Blando, Jorge M., Allison, James P., Xiong, Liangwen, Subudhi, Sumit K., Gao, Jianjun, Sharma, Padmanee · 2016 · Nature Communications
Cell-state dynamics and therapeutic resistance in melanoma from the perspective of MITF and IFNγ pathways
Bai, Xue, Fisher, David E., Flaherty, Keith T. · 2019 · Nature Reviews Clinical Oncology
Peripheral CD8 effector-memory type 1 T-cells correlate with outcome in ipilimumab-treated stage IV melanoma patients
Wistuba-Hamprecht, Kilian, Martens, Alexander, Heubach, Florian, Romano, Emanuela, Geukes Foppen, Marnix, Yuan, Jianda, Postow, Michael, Wong, Phillip, Mallardo, Domenico, Schilling, Bastian et al. · 2017 · European Journal of Cancer
Autoimmune endocrine dysfunctions associated with cancer immunotherapies
Ferrari, Silvia Martina, Fallahi, Poupak, Elia, Giusy, Ragusa, Francesca, Ruffilli, Ilaria, Patrizio, Armando, Galdiero, Maria Rosaria, Baldini, Enke, Ulisse, Salvatore, Marone, Gianni et al. · 2019 · International Journal of Molecular Sciences
Safety and efficacy of ipilimumab to treat advanced melanoma in the setting of liver transplantation
Morales, Rita E, Shoushtari, Alexander N, Walsh, Michelle M, Grewal, Priya, Lipson, Evan J, Carvajal, Richard D · 2015 · Journal for ImmunoTherapy of Cancer
COX-2 expression positively correlates with PD-L1 expression in human melanoma cells
Botti, Gerardo, Fratangelo, Federica, Cerrone, Margherita, Liguori, Giuseppina, Cantile, Monica, Anniciello, Anna Maria, Scala, Stefania, D’Alterio, Crescenzo, Trimarco, Chiara, Ianaro, Angela et al. · 2017 · Journal of Translational Medicine
Gastrointestinal toxicity of immune checkpoint inhibitors: From mechanisms to management
Samaan, Mark A., Pavlidis, Polychronis, Papa, Sophie, Powell, Nick, Irving, Peter M. · 2018 · Nature Reviews Gastroenterology & Hepatology
The RNA-binding Protein MEX3B Mediates Resistance to Cancer Immunotherapy by Downregulating HLA-A Expression
Huang, Lu, Malu, Shruti, McKenzie, Jodi A., Andrews, Miles C., Talukder, Amjad H., Tieu, Trang, Karpinets, Tatiana, Haymaker, Cara, Forget, Marie-Andrée, Williams, Leila J. et al. · 2018 · Clinical Cancer Research
Phase i trial of a recombinant yeast-CEA vaccine (GI-6207) in adults with metastatic CEA-expressing carcinoma
Bilusic, Marijo, Heery, Christopher R., Arlen, Philip M., Rauckhorst, Myrna, Apelian, David, Tsang, Kwong Y., Tucker, Jo A., Jochems, Caroline, Schlom, Jeffrey, Gulley, James L. et al. · 2014 · Cancer Immunology, Immunotherapy
Treg Fragility: A Prerequisite for Effective Antitumor Immunity?
Overacre-Delgoffe, Abigail E., Vignali, Dario A.A. · 2018 · Cancer Immunology Research
Survivorship in Immune Therapy: Assessing Chronic Immune Toxicities, Health Outcomes, and Functional Status among Long-term Ipilimumab Survivors at a Single Referral Center
Johnson, Douglas B., Friedman, Debra L., Berry, Elizabeth, Decker, Ilka, Ye, Fei, Zhao, Shilin, Morgans, Alicia K., Puzanov, Igor, Sosman, Jeffrey A., Lovly, Christine M. · 2015 · Cancer Immunology Research
Phase II study of ipilimumab in adolescents with unresectable stage III or IV malignant melanoma
Geoerger, Birgit, Bergeron, Christophe, Gore, Lia, Sender, Leonard, Dunkel, Ira J., Herzog, Cynthia, Brochez, Lieve, Cruz, Ofelia, Nysom, Karsten, Berghorn, Elmer et al. · 2017 · European Journal of Cancer
The Impact of Intratumoral and Gastrointestinal Microbiota on Systemic Cancer Therapy
Cogdill, Alexandria P., Gaudreau, Pierre Olivier, Arora, Reetakshi, Gopalakrishnan, Vancheswaran, Wargo, Jennifer A. · 2018 · Trends in Immunology
Autoimmune Myocarditis Caused by Immune Checkpoint Inhibitors Treated With Antithymocyte Globulin
Jain, Varun, Mohebtash, Mahsa, Rodrigo, Maria E., Ruiz, George, Atkins, Michael B., Barac, Ana · 2018 · Journal of Immunotherapy
Epitope spreading toward wild-type melanocyte-lineage antigens rescues suboptimal immune checkpoint blockade responses
Lo, Jennifer A., Kawakubo, Masayoshi, Juneja, Vikram R., Su, Mack Y., Erlich, Tal H., LaFleur, Martin W., Kemeny, Lajos V., Rashid, Mamunur, Malehmir, Mohsen, Rabi, S. Alireza et al. · 2021 · Science Translational Medicine
Cardiotoxicity of Anticancer Therapeutics
Dong, Jerry, Chen, Hong · 2018 · Frontiers in Cardiovascular Medicine
Tumor CTLA-4 overexpression predicts poor survival in patients with nasopharyngeal carcinoma
Huang, Pei-Yu, Guo, Shan-Shan, Zhang, Yu, Lu, Jia-Bin, Chen, Qiu-Yan, Tang, Lin-Quan, Zhang, Lu, Liu, Li-Ting, Zhang, Li, Mai, Hai-Qiang · 2016 · Oncotarget
Aging, immune senescence, and immunotherapy: a comprehensive review
Elias, Rawad, Hartshorn, Kevan, Rahma, Osama, Lin, Nina, Snyder-Cappione, Jennifer E. · 2018 · Seminars in Oncology
Optimizing immune-related tumor response assessment: does reducing the number of lesions impact response assessment in melanoma patients treated with ipilimumab?
Nishino, Mizuki, Gargano, Maria, Suda, Margaret, Ramaiya, Nikhil H, Hodi, F Stephen · 2014 · Journal for ImmunoTherapy of Cancer
Increased PD-1 expression on CD4+ and CD8+ T cells is involved in immune evasion in gastric cancer
Saito, Hiroaki, Kuroda, Hirohiko, Matsunaga, Tomoyuki, Osaki, Tomohiro, Ikeguchi, Masahide · 2013 · Journal of Surgical Oncology
Connecting the dots: therapy-induced senescence and a tumor-suppressive immune microenvironment
Vilgelm, Anna E., Johnson, C. Andrew, Prasad, Nripesh, Yang, Jinming, Chen, Sheau-Chiann, Ayers, Gregory D., Pawlikowski, Jeff S., Raman, Dayanidhi, Sosman, Jeffrey A., Kelley, Mark et al. · 2016 · JNCI Journal of the National Cancer Institute
Epigenetic state determines the in vivo efficacy of STING agonist therapy
Falahat, Rana, Berglund, Anders, Perez-Villarroel, Patricio, Putney, Ryan M., Hamaidi, Imene, Kim, Sungjune, Pilon-Thomas, Shari, Barber, Glen N., Mulé, James J. · 2023 · Nature Communications
Thyroid-Like Ophthalmopathy in a Euthyroid Patient Receiving Ipilimumab
McElnea, Elizabeth, Ní Mhéalóid, Áine, Moran, Sarah, Kelly, Rory, Fulcher, Tim · 2014 · Orbit
Cell signaling and cancer: a mechanistic insight into drug resistance
Panda, Munmun, Biswal, Bijesh K. · 2019 · Molecular Biology Reports
A high-throughput immune-oncology screen identifies EGFR inhibitors as potent enhancers of antigen-specific cytotoxic T-lymphocyte tumor cell killing
Lizotte, Patrick H., Hong, Ruey-Long, Luster, Troy A., Cavanaugh, Megan E., Taus, Luke J., Wang, Stephen, Dhaneshwar, Abha, Mayman, Naomi, Yang, Aaron, Kulkarni, Meghana et al. · 2018 · Cancer Immunology Research
Primary and acquired resistance to EGFR-targeted therapies in colorectal cancer: impact on future treatment strategies
Leto, Simonetta M., Trusolino, Livio · 2014 · Journal of Molecular Medicine
Clonality of CD4+ Blood T Cells Predicts Longer Survival With CTLA4 or PD-1 Checkpoint Inhibition in Advanced Melanoma
Arakawa, Akiko, Vollmer, Sigrid, Tietze, Julia, Galinski, Adrian, Heppt, Markus V., Bürdek, Maja, Berking, Carola, Prinz, Jörg C. · 2019 · Frontiers in Immunology
Haematological malignancies: at the forefront of immunotherapeutic innovation
Bachireddy, Pavan, Burkhardt, Ute E., Rajasagi, Mohini, Wu, Catherine J. · 2015 · Nature Reviews Cancer
Irradiation and immunotherapy: From concept to the clinic
Salama, April K. S., Postow, Michael A., Salama, Joseph K. · 2016 · Cancer
Immunotherapy for metastatic solid cancers
Turcotte, Simon, Rosenberg, Steven A. · 2011 · Advances in Surgery
Molecular Pathways: Immune Checkpoint Antibodies and their Toxicities
Cousin, Sophie, Italiano, Antoine · 2016 · Clinical Cancer Research
Human immunocompetent Organ-on-Chip platforms allow safety profiling of tumor-targeted T-cell bispecific antibodies
Kerns, S Jordan, Belgur, Chaitra, Petropolis, Debora, Kanellias, Marianne, Barrile, Riccardo, Sam, Johannes, Weinzierl, Tina, Fauti, Tanja, Freimoser-Grundschober, Anne, Eckmann, Jan et al. · 2021 · eLife
A severe case of refractory esophageal stenosis induced by nivolumab and responding to tocilizumab therapy
Horisberger, Alice, La Rosa, Stefano, Zurcher, Jean-Philippe, Zimmermann, Stefan, Spertini, Francois, Coukos, George, Obeid, Michel · 2018 · Journal for ImmunoTherapy of Cancer
Tumor-infiltrating immune cells as potential biomarkers predicting response to treatment and survival in patients with metastatic melanoma receiving ipilimumab therapy
Balatoni, Tímea, Mohos, Anita, Papp, Eszter, Sebestyén, Tímea, Liszkay, Gabriella, Oláh, Judit, Varga, Anita, Lengyel, Zsuzsanna, Emri, Gabriella, Gaudi, István et al. · 2018 · Cancer Immunology, Immunotherapy
Evolution of Cancer Vaccines—Challenges, Achievements, and Future Directions
Tay, Ban Qi, Wright, Quentin, Ladwa, Rahul, Perry, Christopher, Leggatt, Graham, Simpson, Fiona, Wells, James W., Panizza, Benedict J., Frazer, Ian H., Cruz, Jazmina L. G. · 2021 · Vaccines
The effect of antibiotics on the clinical outcomes of patients with solid cancers undergoing immune checkpoint inhibitor treatment: a retrospective study
Kim, Hyunho, Lee, Ji Eun, Hong, Sook Hee, Lee, Myung Ah., Kang, Jin Hyoung, Kim, In-Ho · 2019 · BMC Cancer
Trial watch: immune checkpoint blockers for cancer therapy
Vanpouille-Box, Claire, Lhuillier, Claire, Bezu, Lucillia, Aranda, Fernando, Yamazaki, Takahiro, Kepp, Oliver, Fucikova, Jitka, Spisek, Radek, Demaria, Sandra, Formenti, Silvia C. et al. · 2017 · OncoImmunology
Delayed immune-related adverse events in assessment for dose-limiting toxicity in early phase immunotherapy trials
Kanjanapan, Y., Day, D., Butler, M.O., Wang, L., Joshua, A.M., Hogg, D., Leighl, N.B., Razak, A.R. Abdul, Hansen, A.R., Boujos, S. et al. · 2019 · European Journal of Cancer
Phase I Expansion and Pharmacodynamic Study of the Oral MEK Inhibitor RO4987655 (CH4987655) in Selected Patients with Advanced Cancer with <i>RAS–RAF</i> Mutations
Zimmer, Lisa, Barlesi, Fabrice, Martinez-Garcia, Maria, Dieras, Veronique, Schellens, Jan H.M., Spano, Jean-Philippe, Middleton, Mark R., Calvo, Emiliano, Paz-Ares, Luiz, Larkin, James et al. · 2014 · Clinical Cancer Research
Deciphering mechanisms of brain metastasis in melanoma - the gist of the matter
Redmer, Torben · 2018 · Molecular Cancer
Scientific rationale for combination immunotherapy of hepatocellular carcinoma with anti–PD-1/PD-L1 and anti–CTLA-4 antibodies
Kudo, Masatoshi · 2019 · Liver Cancer
Unique cytologic features of thyroiditis caused by immune checkpoint inhibitor therapy for malignant melanoma
Angell, Trevor E., Min, Le, Wieczorek, Tad J., Hodi, F. Stephen · 2018 · Genes & Diseases
Current Progress and Future Perspectives of Immune Checkpoint in Cancer and Infectious Diseases
Cai, Xin, Zhan, Huajie, Ye, Yuguang, Yang, Jinjin, Zhang, Minghui, Li, Jing, Zhuang, Yuan · 2021 · Frontiers in Genetics
Phosphoinositide 3-kinase δ inhibition promotes antitumor responses but antagonizes checkpoint inhibitors
Lim, Ee Lyn, Cugliandolo, Fiorella M., Rosner, Dalya R., Gyori, David, Roychoudhuri, Rahul, Okkenhaug, Klaus · 2018 · JCI Insight
Immunomodulatory Effects of BRAF, MEK, and CDK4/6 Inhibitors: Implications for Combining Targeted Therapy and Immune Checkpoint Blockade for the Treatment of Melanoma
Lelliott, Emily J., McArthur, Grant A., Oliaro, Jane, Sheppard, Karen E. · 2021 · Frontiers in Immunology
Vaccine therapy for pancreatic cancer
Salman, Bulent, Zhou, Donger, Jaffee, Elizabeth M, Edil, Barish H, Zheng, Lei · 2013 · OncoImmunology
Considerations for successful cancer immunotherapy in aged hosts
Hurez, V, Padrón, Á S, Svatek, R S, Curiel, T J · 2016 · Clinical and Experimental Immunology
Immune-Checkpoint Inhibitors (ICIs) in Metastatic Colorectal Cancer (mCRC) Patients beyond Microsatellite Instability
Borelli, Beatrice, Antoniotti, Carlotta, Carullo, Martina, Germani, Marco Maria, Conca, Veronica, Masi, Gianluca · 2022 · Cancers
Reactivity toward Bifidobacterium longum and Enterococcus hirae demonstrate robust CD8+ T cell response and better prognosis in HBV-related hepatocellular carcinoma
Rong, Yihui, Dong, Zheng, Hong, Zhixian, Jin, Yun, Zhang, Wei, Zhang, Bailong, Mao, Wei, Kong, Huifang, Wang, Chunping, Yang, Bin et al. · 2017 · Experimental Cell Research
Immune checkpoint inhibitors in older adults
Elias, Rawad, Morales, Joshua, Rehman, Yasser, Khurshid, Humera · 2016 · Current Oncology Reports
Checkpoint inhibitor-associated drug reaction with eosinophilia and systemic symptom syndrome
Mirza, Sayeef, Hill, Ebone’, Ludlow, Steven P., Nanjappa, Sowmya · 2017 · Melanoma Research
Tremelimumab-Induced Graves Hyperthyroidism
Gan, Earn H., Mitchell, Anna L., Plummer, Ruth, Pearce, Simon, Perros, Petros · 2017 · European Thyroid Journal
Checkpoint immunotherapy in pediatrics: here, gone, and back again
Long, Adrienne H., Morgenstern, Daniel A., Leruste, Amaury, Bourdeaut, Franck, Davis, Kara L. · 2022 · American Society of Clinical Oncology Educational Book
Association of age with efficacy of immunotherapy in metastatic melanoma
Jain, Varsha, Hwang, Wei-Ting, Venigalla, Sriram, Nead, Kevin T., Lukens, John N., Mitchell, Tara C., Shabason, Jacob E. · 2020 · The Oncologist
An intra-patient placebo-controlled phase I trial to evaluate the safety and tolerability of intradermal IMM-101 in melanoma
Stebbing, J., Dalgleish, A., Gifford-Moore, A., Martin, A., Gleeson, C., Wilson, G., Brunet, L.R., Grange, J., Mudan, S. · 2012 · Annals of Oncology